Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
工商银行2025年6月3日量比数据
Type of publications
Guidelines (1)
NITAG documentation (34)
Reports (3)
SAGE documentation (5)
Scientific publications (1)
Systematic reviews (SYSVAC) (195)
Regions
Africa (15)
Americas (16)
Eastern Mediterranean (8)
Europe (23)
South-East Asia (4)
Western Pacific (14)
Diseases
Chikungunya (4)
Cholera (2)
COVID-19 (66)
Cytomegalovirus (1)
Dengue (1)
Diphtheria (1)
Ebola (1)
Haemophilus influenzae type B (1)
Hepatitis A (1)
Hepatitis B (6)
Hepatitis E (1)
Herpes zoster (7)
Human papillomavirus (HPV) (33)
Influenza (32)
Malaria (4)
Measles (7)
Meningococcal disease (5)
Moraxella catarrhalis (1)
Mpox (4)
Pertussis (4)
Pneumococcal disease (14)
Poliomyelitis (3)
Rabies (1)
Rotavirus (5)
RSV (Respiratory syncytial virus) (8)
Salmonella (1)
Tetanus (2)
Tuberculosis (5)
Typhoid (1)
Varicella (3)
Yellow fever (1)
Show more
239 results found
2025
∙
ATAGI
ATAGI statement on the administration of seasonal influenza vaccines in 2025
2025
∙
NACI
Rapid response: Preliminary guidance on human vaccination against avian influenza in a non-pandemic context as of December 2024
2025
∙
CAVEI
CAVEI recommendation on annual vaccination against COVID-19 for the year 2025
2025
∙
NACI
Guidance on the use of COVID-19 vaccines for 2025 to summer 2026
2025
∙
Global NITAG Network
Standard Operating Procedures of the Global NITAG Network
2024
∙
Haute Autorité de Santé
Transition of INFLUVAC influenza vaccine from its quadrivalent form to a trivalent form in the seasonal influenza vaccination strategy in France
2024
∙
NACI
Recommendations on the use of pneumococcal vaccines in adults, including PNEU-C-21
2024
∙
JCVI
Flu vaccines 2025 to 2026: JCVI advice
2024
∙
JCVI
COVID-19 vaccination in 2025 and spring 2026: JCVI advice
2024
∙
ATAGI
ATAGI statement on the transition from quadrivalent to trivalent seasonal influenza vaccines in Australia
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register